Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kentuckiana Cancer Institute
This is a phase I/II study of high dose irinotecan in patients with recurrent unresectable malignant glioma on steroids/anti-epileptics. The purpose is to compare the response to treatment and side effects associated with high dose irinotecan in patients with recurrent brain tumors.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
recurrent, unresectable primary CNS neoplasm per MRI